Irvine, CaliforniaJanuary 20, 2023 /PRNewswire/ — Seragon Biosciences, Inc . Announcing Today the Launch of RESTORIN®, a super nutritional food that promotes a healthy aging process. RESTORIN combines a series of patented technologies from Harvard University, Mayo Clinic and Scripps Research to increase cellular levels of nicotinamide adenine dinucleotide (NAD+) and enhance senolytic stimulation.
RESTORIN is an advanced NAD+ Senolytic supplement designed to promote a healthy aging process.
[廣告] please read on
For decades, the complex nature of aging has left scientists with many unanswered questions in the field of aging interventions. Recent research points to Senolytic and NAD+ as key technologies to address this challenge. RESTORIN is a controlled release Senolytic NAD+ supplement. It also uses Seragon’s SERC™ Targeted Release Technology, enabling hydrophilic and lipophilic carriers and a pH-responsive enteric delivery system to improve ingredient bioavailability.
RESTORIN contains a series of proprietary forms of Senolytic agents, NAD + precursor and Sirtuin active complex (STAC). Senolytics are molecules that target senescent cells – senescent cells that promote aging and lead to organ degeneration. NAD+ is a life-sustaining enzyme that improves cellular energy metabolism and DNA integrity, and fuels sirtuins, long-lived proteins essential to cellular health.
Seragon Senior Scientist David Brown The PhD, who helped develop RESTORIN, said: “Many studies show the positive effect of these molecules on aging and age-related health conditions, but until now nobody has been able to combine them in the best ratios possible to achieve synergistic effects. We have been able to use the best science we have to develop advanced forms of these molecules and a range of complex combinations to fight ageing. This is truly a game changer.”
Decades of research have shown that NAD+ levels drop dramatically as we age, increasing our vulnerability to age-related health conditions ranging from diabetes to neurodegeneration. Replenishment of NAD+ levels is essential to slow aging. However, effectively enhancing NAD+ at the cellular level through oral delivery has been challenging.
“In the field of aging, a key question that needs to be addressed is how to deliver NAD+ precursors in a way that best promotes cellular NAD+ for healthier ageing. We believe that RESTORIN achieves best-in-class performance in of this,” said Dr Brown, this is truly groundbreaking. It’s very exciting to be a part of this development, especially considering recent studies showing that an increase in NAD+ may even make anti-cancer immunotherapy more effective.”
He added: “It’s exciting to see aging research moving forward to help people age in a slower, better and healthier way.”
RESTORIN is only available to users through its official website at:
for Seragon Biosciences
Seragon Biosciences, Inc., headquartered in Irvine, California, is a research-based biopharmaceutical company dedicated to improving human and animal health through innovative science. Seragon Biosciences is committed to applying cutting-edge scientific and technological advances in the fields of aging, metabolism, gene therapy and bioinformatics. From research to consumer products and clinical applications, Seragon is committed to enabling the most significant advances in medicine. For more information, visit:
